You have 9 free searches left this month | for more free features.

Weekly

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ovarian Cancer Trial in Houston (Paclitaxel, Bevacizumab, Lurbinectedin)

Not yet recruiting
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2022

Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

Active, not recruiting
  • Bioequivalence
  • Rivastigmine twice-weekly 9,5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thuringia, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023

MDS, AML Trial in Bronx (Venetoclax, Decitabine)

Recruiting
  • MDS
  • AML
  • Bronx, New York
    Montefiore Medical Center
Jul 22, 2022

HIV Seropositivity, Tuberculosis, Household Contact Trial in Klerksdorp (Daily rifapentine and isoniazid for 4 weeks, Weekly

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Daily rifapentine and isoniazid for 4 weeks
  • Weekly rifapentine and isoniazid for 12 weeks
  • Klerksdorp, North West Province, South Africa
    The Aurum Institute: Gavin J Churchyard Legacy Centre
Jan 31, 2023

Breast Cancer Trial in Tampa (Eribulin, Carboplatin)

Completed
  • Breast Cancer
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022

Double Diabetes Trial in Dijon (Insulin + semaglutide treatment, Usual insulin treatment, Biological check-up)

Recruiting
  • Double Diabetes
  • Insulin + semaglutide treatment
  • +2 more
  • Dijon, France
    Chu Dijon Bourgogne
Jul 18, 2022

Breast Tumors, Locally Advanced or Metastatic Breast Cancer Trial (utidelone)

Not yet recruiting
  • Breast Neoplasms
  • Locally Advanced or Metastatic Breast Cancer
  • (no location specified)
May 30, 2022

Tuberculosis, Latent Tuberculosis, HIV/AIDS Trial in Kampala (Streamlined weekly DOT visits, Weekly DOT visit reminders, Cost

Active, not recruiting
  • Tuberculosis
  • +2 more
  • Streamlined weekly DOT visits
  • +5 more
  • Kampala, Uganda
    Mulago Immune Suppression Syndrome (ISS) Clinic
Nov 28, 2022

Cervical Cancer Trial in Heidelberg (MR-guided radiation)

Recruiting
  • Cervical Cancer
  • MR-guided radiation
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 15, 2023

NSCLC Trial in United States (Napabucasin, Paclitaxel)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • Beverly Hills, California
  • +4 more
Apr 4, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in New Haven, Baltimore (Ixabepilone,

Active, not recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • New Haven, Connecticut
  • +1 more
Jan 11, 2023

Kidney Failure, Chronic, Heart Failure Trial in Jackson (Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing,

Not yet recruiting
  • Kidney Failure, Chronic
  • Heart Failure
  • Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing
  • Empagliflozin 10 mg daily dosing
  • Jackson, Mississippi
    University of Mississippi Medical Center
Jan 19, 2023

Diabetes, Type 2 Trial in Santiago, Región Metropolitana (Semaglutide)

Recruiting
  • Diabetes Mellitus, Type 2
  • Santiago, Región Metropolitana, Chile
  • +2 more
Sep 9, 2022

Acne Vulgaris Trial in Charleston (Isotretinoin)

Completed
  • Acne Vulgaris
  • Charleston, South Carolina
    Samantha Karline
Apr 11, 2022

Chronic Kidney Disease (CKD) Stage 5, Kidney Dysfunction Requiring Dialysis (KDRD), Dialysis Dependency Trial in Long Beach

Not yet recruiting
  • Chronic Kidney Disease (CKD) Stage 5
  • +2 more
  • Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule
  • Thrice-Weekly Hemodialysis
  • Long Beach, California
    VA Long Beach Healthcare System, Long Beach, CA
Aug 16, 2022

Diabetes, Type 2, Weight Change, Body Trial in Peshawar, Karachi (Semaglutide Pen Injector)

Recruiting
  • Diabetes Mellitus, Type 2
  • Weight Change, Body
  • Semaglutide Pen Injector
  • Peshawar, KPK, Pakistan
  • +1 more
Aug 3, 2022

HER2-positive Breast Cancer Trial in Tampa (biological, drug, procedure)

Recruiting
  • HER2-positive Breast Cancer
  • HER-2 pulsed DC1
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 6, 2022

Acute Schizophrenia Trial in Kure-shi (OPC-34712FUM/ Brexpiprazole fumarate, Placebo)

Recruiting
  • Acute Schizophrenia
  • OPC-34712FUM/ Brexpiprazole fumarate
  • Placebo
  • Kure-shi, Japan
    Hayakawa Clinic
Jul 26, 2022

Healthy Volunteers Trial run by the CC (Vemlidy (tenofivir alafenamide), Priftin (rifapentine), Isoniazid)

Recruiting
  • Healthy Volunteers
  • Vemlidy (tenofivir alafenamide)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 27, 2022

Alendronate inWeekly Effervescent Tablet Formulation Following

Recruiting
  • Postmenopausal Osteoporosis
  • Binosto 70Mg Effervescent Tablet
  • Athens, Attiki, Greece
    251 Hellenic Air Force & VA General Hospital
Nov 6, 2022

Bardet-Biedl Syndrome, POMC Deficiency Trial in Marshfield (Setmelanotide 20mg weekly, Placebo daily, Setmelanotide 30mg weekly)

Enrolling by invitation
  • Bardet-Biedl Syndrome
  • POMC Deficiency
  • Setmelanotide 20mg weekly
  • +5 more
  • Marshfield, Wisconsin
    Marshfield Clinic Research Institute
Jan 25, 2022

COVID-19, Coronavirus, Coronavirus Infections Trial in Detroit (drug, other, diagnostic test)

Terminated
  • COVID-19
  • +3 more
  • Hydroxychloroquine - Daily Dosing
  • +6 more
  • Detroit, Michigan
    Henry Ford Hospital
Jun 15, 2022

Distracted Driving, Impaired Driving, Driving Behaviors Trial in Philadelphia (Persuasive education, WOOP (aka, mental

Not yet recruiting
  • Distracted Driving
  • +2 more
  • Persuasive education
  • +6 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 8, 2022

Depression, Anxiety Trial in New York (Message-based psychotherapy (MBP), Video-chat Psychotherapy (VCP))

Completed
  • Depression
  • Anxiety
  • Message-based psychotherapy (MBP)
  • Video-chat Psychotherapy (VCP)
  • New York, New York
    Talkspace
Jul 18, 2022

HIV Seropositivity, Pregnancy, Tuberculosis Infection Trial in Tembisa (Rifapentine, Isoniazid)

Not yet recruiting
  • HIV Seropositivity
  • +2 more
  • Tembisa, Gauteng, South Africa
    The Aurum Institute: Tembisa Clinical Research Centre
Dec 9, 2022